Clinical Trial Update: The Effect of Allopurinol on Insulin Resistance and Blood Pressure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allopurinol for insulin resistance and blood pressure in metabolic syndrome has completed; the update does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Hospital Mateo Orfila | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED